Sara Anvari, MD, MSc, FAAP, FACAAI, FAAAAI
Dr. Sara Anvari is an Associate Professor of Pediatrics at Baylor College of Medicine and Texas Children’s Hospital, where she serves as Director of Clinical Trials and Translational Research for the Allergy and Immunology Program. She is also the Medical Director of the FPIES Clinic and the Penicillin Allergy Delabeling Clinic, and has developed multidisciplinary clinical programs focused on complex food allergy and adverse drug and vaccine reactions.
Dr. Anvari’s research and clinical work focus on food allergy, including Food Protein-Induced Enterocolitis Syndrome (FPIES), drug hypersensitivity, and vaccine allergy. She leads multicenter clinical trials and registry-based studies aimed at improving diagnosis, understanding disease mechanisms, and advancing patient-centered care.
She is actively involved in national leadership through the American Academy of Allergy, Asthma & Immunology (AAAAI), where she contributes to multiple committees focused on drug, biologic, and vaccine reactions, as well as anaphylaxis. Dr. Anvari is recognized for her collaborative approach to care, mentorship of trainees and junior faculty, and commitment to advancing evidence-based management for allergic diseases.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:RegeneronTopic:Research GrantDate added:06/16/2026Date updated:06/16/2026
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:NIAID/NIHTopic:Research GrantsDate added:06/16/2026Date updated:06/16/2026
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Astra ZenecaTopic:Research GrantDate added:06/16/2026Date updated:06/16/2026
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:DBV TechnologiesTopic:Research GrantDate added:06/16/2026Date updated:06/16/2026
-
Attribution:SelfType of financial relationship:TravelIneligible company:FARETopic:HonorariumDate added:06/16/2026Date updated:06/16/2026
-
Attribution:SelfType of financial relationship:TravelIneligible company:GenentechTopic:Advisory BoardDate added:06/16/2026Date updated:06/16/2026
-
Attribution:SelfType of financial relationship:TravelIneligible company:ACAAITopic:Speaker HonorariumDate added:06/16/2026Date updated:06/16/2026

Facebook
X
LinkedIn
Forward